Press release
Chemotherapy Induced Nausea and Vomiting CINV Market Set to Reach 4.2 Billion by 2029 with 7.5% Yearly Growth
Chemotherapy Induced Nausea and Vomiting CINV Market
The chemotherapy-induced nausea and vomiting (CINV) market has experienced strong growth in recent years. It will grow from $2.92 billion in 2024 to $3.15 billion in 2025, reflecting a CAGR of 7.9%. Growth is driven by the increasing use of chemotherapy, improved antiemetic agents, updated clinical guidelines, and patient advocacy efforts.
The chemotherapy-induced nausea and vomiting (CINV) market is expected to reach $4.2 billion by 2029 at a CAGR of 7.5%, with growth supported by personalized medicine, advances in antiemetic agents, and telehealth. Trends include combination antiemetic therapies and digital health tools for survivorship care.
What Are the Forces Behind the Rapid Growth of the Chemotherapy Induced Nausea and Vomiting CINV Market?
The increasing prevalence of cancer is expected to propel the growth of the chemotherapy-induced nausea and vomiting (CINV) market. As cancer cases rise, there is a greater demand for treatments to manage side effects like CINV. The expected 1.9 million new cancer cases in the US in 2023 indicates a growing market for anti-emetic therapies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13031&type=smp
Who Are the Dominant Companies Influencing Chemotherapy Induced Nausea and Vomiting CINV Market Trends?
Major companies operating in the chemotherapy-induced nausea and vomiting (cinv) market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca PLC, GlaxoSmithKline PLC, Baxter International Inc., Teva Pharmaceuticals Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals PLC, Ono Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Kyowa Kirin Inc., Amneal Pharmaceuticals Inc., Mundipharma International Limited, Insys Therapeutics Inc., Lupin Limited, Helsinn Holding S.A., Heron Therapeutics Inc., Camurus AB, Cadila Pharmaceuticals Limited, Acacia Pharma Ltd., Soligenix Inc.
How Is the Chemotherapy Induced Nausea and Vomiting CINV Market Evolving?
Key players in the chemotherapy-induced nausea and vomiting (CINV) market are focused on innovating new products, such as fixed intravenous antiemetics, to gain a competitive edge. A fixed intravenous antiemetic refers to a pre-measured dose of medication administered intravenously to prevent or treat nausea and vomiting, commonly used during chemotherapy or post-surgery. For instance, in January 2023, Glenmark Pharmaceuticals Limited, based in India, launched AKYNZEO I.V., the first fixed intravenous antiemetic combination in India designed to address chemotherapy-induced nausea and vomiting (CINV). The product combines netupitant and palonosetron to target both acute and delayed phases of nausea and vomiting, offering a single-dose solution that improves response rates and quality of life for cancer patients. Clinical trials show it is especially effective for patients undergoing highly emetogenic chemotherapy.
What Are the Different Segmentations in the Chemotherapy Induced Nausea and Vomiting CINV Market?
The chemotherapy-induced nausea and vomiting (CINV) market covered in this report is segmented -
1) By Form: Injectables, Oral, Transdermal Patches
2) By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class
3) By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)
4) By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores
5) By Application: Gynecology, Urology, Gastrointestinal Surgery, Other Applications
Subsegments:
1) By Injectables: Intravenous (IV) Solutions, Intramuscular (IM) Injections
2) By Oral: Tablets, Capsules, Liquid Formulations
3) By Transdermal Patches: Fentanyl Patches, Scopolamine Patches
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-nausea-and-vomiting-cinv-global-market-report
Which Region Is at the Forefront of the Chemotherapy Induced Nausea and Vomiting CINV Market?
North America was the largest region in the chemotherapy-induced nausea and vomiting (CINV) market in 2024. The regions covered in chemotherapy-induced nausea and vomiting (CINV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Chemotherapy Induced Nausea and Vomiting CINV Global Market Report?
- Market Size Analysis: Analyze the Chemotherapy Induced Nausea and Vomiting CINV Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Chemotherapy Induced Nausea and Vomiting CINV Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Chemotherapy Induced Nausea and Vomiting CINV Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Chemotherapy Induced Nausea and Vomiting CINV Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13031
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chemotherapy Induced Nausea and Vomiting CINV Market Set to Reach 4.2 Billion by 2029 with 7.5% Yearly Growth here
News-ID: 3847956 • Views: …
More Releases from The Business Research Company
Future of Printing Inks Market: Size, Share & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Printing Inks Market by 2025?
The market size for printing inks has seen consistent expansion over the last few years. The projections estimate an increase from $36.79 billion in 2024 to $38.15 billion in 2025, indicating a Compound Annual Growth Rate (CAGR)…
Plasticizers Market Size to Reach $135.58 Billion by 2029 | Growth at 8.3% CAGR …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Plasticizers Industry?
In recent times, the plasticizers market has seen significant expansion. The market, which is projected to surge from $91.81 billion in 2024 to $98.62 billion in 2025, is expected to witness a Compound Annual Growth Rate (CAGR) of 7.4%. Factors contributing…
Pesticide And Other Agricultural Chemicals Industry Set to Achieve $156.05 Billi …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Pesticide And Other Agricultural Chemicals Market Size 2025?
In recent years, the market size for pesticides and other agricultural chemicals has witnessed significant growth. From a value of $104.46 billion in 2024, it's projected to swell to $113.13 billion in 2025, reflecting a compound…
Organophosphates Pesticides Industry Expected to Reach $10.67 Billion by 2029 at …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Organophosphates Pesticides Market Value Projection: How Much Will the Market Size by 2025?
The market size of organophosphates pesticides has experienced consistent growth in the prior years. The market is projected to expand from $8.05 billion in 2024 to $8.41 billion in 2025, with a compound annual growth rate (CAGR) of…
More Releases for CINV
Emerging Trends Influencing The Growth Of The Chemotherapy-Induced Nausea and Vo …
The Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Expected to Be by 2034?
There has been a notable growth in the market size of chemotherapy-induced nausea and vomiting (CINV)…
Key Influencer in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market 202 …
How Are the key drivers contributing to the expansion of the chemotherapy-induced nausea and vomiting (cinv) market?
The escalating cases of cancer are expected to foster the expansion of the market for chemotherapy-induced nausea and vomiting (CINV). This rise is due to the uncontrolled development and spread of cancer cells in the body. As cancer prevalence increases, there's an increased drive to produce highly effective and specific anti-emetic treatments, which would…
Advancements and Trends in the Global Chemotherapy-induced Nausea and Vomiting ( …
Introduction:
The realm of cancer treatment is a dynamic arena where advancements continuously unfold. Among the multitude of challenges that cancer patients face, chemotherapy-induced nausea and vomiting (CINV) is a formidable adversary. In this article, we delve into the intricate landscape of the CINV market, exploring its evolution, current state, and future prospects.
Understanding CINV:
CINV, an acronym that echoes the discomfort experienced by countless individuals, stands for chemotherapy-induced nausea and vomiting. This…
CINV Existing and Pipeline Drugs Market: Rising Demand for CINV Drugs Owing to I …
CINV drugs are administered to patients suffering from vomiting and nausea that occurs as a side effect of chemotherapy. CINV can hinder the progress of patients undergoing chemotherapy, making it very crucial for oncologists to prescribe the right kind of CINV drugs to alleviate the discomfort. Delayed CINV and acute CINV are the two major subtypes of this condition. While the former occurs up to five days after treatment, the…
CINV Existing and Pipeline Drugs Market : Growing number of patients undergoing …
The growth of the global chemotherapy induced nausea and vomiting (CINV) market will be steered by the growing number of patients undergoing chemotherapy and a number of new drugs expected to be approved in the near future, says Transparency Market Research. In its report, titled “CINV Existing and Pipeline Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” the business intelligence firm says that…
Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Research Re …
This report studies Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
GlaxoSmithKline Plc
Helsinn Group
Heron Therapeutics
Merck & Co Inc
Tesaro
...
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of…
